These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 21388622)

  • 1. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial.
    Dai YL; Luk TH; Yiu KH; Wang M; Yip PM; Lee SW; Li SW; Tam S; Fong B; Lau CP; Siu CW; Tse HF
    Atherosclerosis; 2011 Jun; 216(2):395-401. PubMed ID: 21388622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH; Lau KK; Yiu KH; Li SW; Chan HT; Fong DY; Tam S; Lau CP; Tse HF
    Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study.
    Tiano L; Belardinelli R; Carnevali P; Principi F; Seddaiu G; Littarru GP
    Eur Heart J; 2007 Sep; 28(18):2249-55. PubMed ID: 17644511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
    Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
    Hamilton SJ; Chew GT; Watts GF
    Diabetes Care; 2009 May; 32(5):810-2. PubMed ID: 19228872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 and exercise training in chronic heart failure.
    Belardinelli R; Muçaj A; Lacalaprice F; Solenghi M; Seddaiu G; Principi F; Tiano L; Littarru GP
    Eur Heart J; 2006 Nov; 27(22):2675-81. PubMed ID: 16882678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial.
    Luk TH; Dai YL; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Fong B; Wong WK; Tam S; Lau CP; Tse HF
    Eur J Prev Cardiol; 2012 Aug; 19(4):830-9. PubMed ID: 21724681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V
    Cardiovasc Diabetol; 2024 Jul; 23(1):245. PubMed ID: 38987784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
    Lee BJ; Huang YC; Chen SJ; Lin PT
    Nutrition; 2012 Jul; 28(7-8):767-72. PubMed ID: 22342390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
    Pelliccia F; Pasceri V; Cianfrocca C; Vitale C; Speciale G; Gaudio C; Rosano GM; Mercuro G
    Atherosclerosis; 2010 Jun; 210(2):510-5. PubMed ID: 20044087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
    Safarinejad MR
    Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sodium and potassium supplementation on endothelial function: a fully controlled dietary intervention study.
    Gijsbers L; Dower JI; Schalkwijk CG; Kusters YH; Bakker SJ; Hollman PC; Geleijnse JM
    Br J Nutr; 2015 Nov; 114(9):1419-26. PubMed ID: 26343780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study.
    Enseleit F; Sudano I; Périat D; Winnik S; Wolfrum M; Flammer AJ; Fröhlich GM; Kaiser P; Hirt A; Haile SR; Krasniqi N; Matter CM; Uhlenhut K; Högger P; Neidhart M; Lüscher TF; Ruschitzka F; Noll G
    Eur Heart J; 2012 Jul; 33(13):1589-97. PubMed ID: 22240497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers.
    Kato T; Inoue T; Morooka T; Yoshimoto N; Node K
    Can J Physiol Pharmacol; 2006 May; 84(5):523-9. PubMed ID: 16902597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease.
    Dai YL; Luk TH; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Tam S; Fong B; Lau CP; Tse HF
    Cardiovasc Toxicol; 2010 Jun; 10(2):130-8. PubMed ID: 20383667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.